272 related articles for article (PubMed ID: 24109594)
21. Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha.
Ko S; Shi L; Kim S; Song CS; Chatterjee B
Mol Endocrinol; 2008 Feb; 22(2):273-86. PubMed ID: 17975021
[TBL] [Abstract][Full Text] [Related]
22. Growth inhibitory concentrations of androgens up-regulate insulin-like growth factor binding protein-3 expression via an androgen response element in LNCaP human prostate cancer cells.
Peng L; Malloy PJ; Wang J; Feldman D
Endocrinology; 2006 Oct; 147(10):4599-607. PubMed ID: 16825320
[TBL] [Abstract][Full Text] [Related]
23. Intratumoral androgen levels are linked to TMPRSS2-ERG fusion in prostate cancer.
Knuuttila M; Mehmood A; Mäki-Jouppila J; Ryberg H; Taimen P; Knaapila J; Ettala O; Boström PJ; Ohlsson C; Venäläinen MS; Laiho A; Elo LL; Sipilä P; Mäkelä SI; Poutanen M
Endocr Relat Cancer; 2018 Sep; 25(9):807-819. PubMed ID: 29773553
[TBL] [Abstract][Full Text] [Related]
24. Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element.
Magee JA; Chang LW; Stormo GD; Milbrandt J
Endocrinology; 2006 Jan; 147(1):590-8. PubMed ID: 16210365
[TBL] [Abstract][Full Text] [Related]
25. Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide.
Nickols NG; Dervan PB
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10418-23. PubMed ID: 17566103
[TBL] [Abstract][Full Text] [Related]
26. Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene.
Jain A; Lam A; Vivanco I; Carey MF; Reiter RE
Mol Endocrinol; 2002 Oct; 16(10):2323-37. PubMed ID: 12351697
[TBL] [Abstract][Full Text] [Related]
27. [The progress of TMPRSS2-ETS gene fusions and their mechanism in prostate cancer].
Guo XQ; Gui YT; Cai ZM
Yi Chuan; 2011 Feb; 33(2):117-22. PubMed ID: 21377967
[TBL] [Abstract][Full Text] [Related]
28. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer.
Thangapazham R; Saenz F; Katta S; Mohamed AA; Tan SH; Petrovics G; Srivastava S; Dobi A
BMC Cancer; 2014 Jan; 14():16. PubMed ID: 24418414
[TBL] [Abstract][Full Text] [Related]
29. Androgen Receptor-Activated Enhancers Simultaneously Regulate Oncogene
Chen Z; Song X; Li Q; Xie L; Guo T; Su T; Tang C; Chang X; Liang B; Huang D
Cells; 2019 Aug; 8(8):. PubMed ID: 31405024
[TBL] [Abstract][Full Text] [Related]
30. TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers.
Mani RS; Iyer MK; Cao Q; Brenner JC; Wang L; Ghosh A; Cao X; Lonigro RJ; Tomlins SA; Varambally S; Chinnaiyan AM
Cancer Res; 2011 Aug; 71(16):5387-92. PubMed ID: 21676887
[TBL] [Abstract][Full Text] [Related]
31. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Tomlins SA; Rhodes DR; Perner S; Dhanasekaran SM; Mehra R; Sun XW; Varambally S; Cao X; Tchinda J; Kuefer R; Lee C; Montie JE; Shah RB; Pienta KJ; Rubin MA; Chinnaiyan AM
Science; 2005 Oct; 310(5748):644-8. PubMed ID: 16254181
[TBL] [Abstract][Full Text] [Related]
32. Secretoglobin 2A1 is under selective androgen control mediated by a peculiar binding site for Sp family transcription factors.
Xiao F; Mirwald A; Papaioannou M; Baniahmad A; Klug J
Mol Endocrinol; 2005 Dec; 19(12):2964-78. PubMed ID: 16020486
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.
Wright JB; Brown SJ; Cole MD
Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031
[TBL] [Abstract][Full Text] [Related]
34. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2.
Lin B; Ferguson C; White JT; Wang S; Vessella R; True LD; Hood L; Nelson PS
Cancer Res; 1999 Sep; 59(17):4180-4. PubMed ID: 10485450
[TBL] [Abstract][Full Text] [Related]
35. CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2.
Seo WY; Jeong BC; Yu EJ; Kim HJ; Kim SH; Lim JE; Kwon GY; Lee HM; Kim JH
Nucleic Acids Res; 2013 Oct; 41(18):8526-36. PubMed ID: 23887938
[TBL] [Abstract][Full Text] [Related]
36. Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.
Toropainen S; Niskanen EA; Malinen M; Sutinen P; Kaikkonen MU; Palvimo JJ
Sci Rep; 2016 Sep; 6():33510. PubMed ID: 27641228
[TBL] [Abstract][Full Text] [Related]
37. The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1.
Simon MP; Tournaire R; Pouyssegur J
J Cell Physiol; 2008 Dec; 217(3):809-18. PubMed ID: 18720385
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of two androgen response regions in the human neutral endopeptidase gene.
Shen R; Sumitomo M; Dai J; Hardy DO; Navarro D; Usmani B; Papandreou CN; Hersh LB; Shipp MA; Freedman LP; Nanus DM
Mol Cell Endocrinol; 2000 Dec; 170(1-2):131-42. PubMed ID: 11162897
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of senescence marker protein-30 gene promoter: identification of repressor elements and functional nuclear factor binding sites.
Rath B; Pandey RS; Debata PR; Maruyama N; Supakar PC
BMC Mol Biol; 2008 Apr; 9():43. PubMed ID: 18442420
[TBL] [Abstract][Full Text] [Related]
40. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.
Iljin K; Wolf M; Edgren H; Gupta S; Kilpinen S; Skotheim RI; Peltola M; Smit F; Verhaegh G; Schalken J; Nees M; Kallioniemi O
Cancer Res; 2006 Nov; 66(21):10242-6. PubMed ID: 17079440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
